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Abstract
Crumb rubber, an infill substance made from repurposed tires, has been examined for
its carcinogenic potential but no studies have looked at its endocrine disrupting potential
to date. After prioritizing 306 chemical components of crumb rubber using computational
models, four endocrine disrupting chemicals (EDCs) thought to possess estrogenic
activity were chosen for further in vitro testing. In addition to these chemicals, a crumb
rubber concentrated media (CRCM) was created for mixture analysis. Gene expression
assays for estrogenic activity were conducted on Ishikawa, HepG2 and MCF-7
immortalized cell lines exposed to 4-tert-octylphenol, dibenz(a,h)anthracene,
fluoranthene, chrysene and CRCM. Based on the findings of this study, crumb rubber is
a potential mediating factor in harmful reproductive outcomes. Further discussion is
needed to juxtapose these biological models with exposure assessment.
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Evaluation of the Endocrine Disrupting Potential of Chemicals Used in Crumb Rubber: A
Multi-Factorial Approach
Alexia Akbay, Department of Environmental Health Sciences, Yale School of Public Health
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| Introduction
According to the EPA, around 290 million tires are disposed of annually in the United

States.1 The disposal of tires poses unique issues to waste management due to their large size
(75% void space), fire hazard potential, and natural breeding ground for mosquitoes.2 For these
reasons many states have regulated tire disposal; 40 states do not allow whole tires in landfills,
and 12 states do not allow cut or shred tires.3 With almost one scrap tire generated per person
annually in the US,4 the EPA and state governments alike have supported the repurposing of
tires into consumer products. For example, the California Department of Resources Recycling
and Recovery (CalRecycle) administers a tire grant program to divert waste products from
landfills5, and the state of Missouri issues waste tire playground grants with rewards up to
$30,000 for installation of tire-derived materials.6
One of these repurposed products is known as “crumb rubber,” an infill substance utilized in
synthetic athletic turf, as well as community parks and school playgrounds. With ease of upkeep
and long-term savings compared to natural grass, this alternative has gained traction globally.7
In the United States, there are over 12,000 synthetic turf fields and an additional 13,000 in
Europe.8 The infill material is composed of rubber polymer (40-60%), reinforcing agents (2035%), aromatic extender oil (<28%), vulcanization additives, antioxidants, antiozonants, and

7

processing aids, such as plasticizers and softeners.9,10 Consequently, the chemicals
measurable in crumb rubber include polycyclic aromatic hydrocarbons (PAHs), volatile organic
compounds (VOCs), semi-volatile organic compounds (SVOCs), and metals, such as lead and
zinc.11
One previous study identified the chemicals present in crumb rubber, characterized
exposure mechanisms, and investigated the suspected carcinogenicity of the chemicals found
in crumb rubber12. There have been no studies investigating the endocrine disrupting potential
of these chemicals to date. An endocrine disrupting chemical (EDC) is an exogenous substance
or mixture that alters the function(s) of the endocrine system by acting as a mimic or competitor
to endogenous hormones in the human body. By disrupting overall hormonal equilibrium, EDCs
can cause adverse health outcomes to an individual or its offspring. Topics of strongest
evidence for endocrine disruption in the literature include obesity and diabetes, female
reproduction, male reproduction, hormone-sensitive cancers in women females, prostate,
thyroid and neurodevelopment and neuroendocrine systems.13 EDCs are an emerging area of
concern in the realm of environmental health risk assessment and toxicology and represent vast
gaps in our understanding of exposures. Typically, chemicals are screened for their
carcinogenic (genotoxic) potential but not specifically for hormonal disruption.
There are unexplained trends in reproductive dysfunction that coincide with the rise of
industrial manufacturing and dissemination of widespread exposure to chemicals with endocrine
disrupting potential. These trends include an average sperm count decrease of 59% from 1973
to 201114 and earlier start to puberty in women15 shown to be correlated with increased levels of
breast cancer16 in epidemiologic findings. It is widely hypothesized that these trends are the
result of exposure to endocrine disrupters, underscoring the need for increased understanding
and identification of chemicals that could be acting via these mechanisms. While there are
many potential effects of EDCs, estrogen receptor signaling is a well-characterized endpoint in
wildlife and humans that is sensitive to the EDC exposure [reference]. Estrogen is a significant
8

factor in both male and female reproductive regulation; mainly, promoting the development and
maintenance of female characteristics in the human body such as breasts and the regulation of
both the reproductive and menstrual cycles. Moreover, EDCs often display a similar structure to
that of endogenous estradiol (E2), the form of estrogen most strongly related to development of
cancer in females.
Being that there are over 140,000 chemicals in commerce with less than 10 percent
screened for toxic endpoints, identifying and testing for endocrine disruption would add a further
financial burden. However, emerging computational models allow for the strategic structural
prioritization of chemicals to aid in weighting research targets.18 This study provides a strategic
two-pronged approach to conducting toxicological research on endocrine disruptors; first we
utilized structural modeling and screening databases to prioritize the testing of potential EDCs
among 300 crumb rubber chemicals, then we evaluated the endogenous estrogenic activity in a
human uterine cell line to evaluate experimental endpoints in relation to computational findings.
To account for the aggregated effect of crumb rubber as a mixture, a crumb rubber conditioned
media (CRCM) was developed and evaluated in experimental endpoints.

2 | Materials and Methods

2.1 | Computational Prioritization.
Chemicals aggregated for carcinogenicity analysis by literature review in a previous
study12 were screened using the Collaborative Estrogen Receptor Activity Prediction
Project (CERAPP)19 and the Collaborative Modeling Project for Androgen Receptor Activity
(CoMPARA)20 models built and validated by the EPA. These models are quantitative structureactivity relationship models that predict the effect on the estrogen and androgen receptors and
their activity.
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(i)

CERAPP, the ER pathway model, demonstrates a balanced prediction accuracy
of 95.2% against agonist reference chemicals and 97.5% when predicting the
antagonist reference chemicals compared to the reference data sets.19 After
identifying 7,253 chemicals with quantitative endpoints by literature review (e.g.
PC50, 50% of response induced by positive control or EC50, concentration of
agonist that induces a response halfway between the baseline and maximum
response), a subset of 36 active and inactive chemicals were chosen as the
reference set. These 36 chemicals were chosen as a result of disagreement
within the available literature pool being less than 20% between studies. The
CERAPP model maps quantitative potency activity as categorical potent classes
based on dose-response data: strong, moderate, weak, very weak, and inactive.
Thresholds defining these five classes, for binding, agonist and antagonist
activity, are defined as follows: (a) Strong: Activity concentration below 0.09 μM,
(b) Moderate: Activity concentration between 0.09 and 0.18 μM, (c) Weak:
Activity concentration between 0.18 and 20 μM. (d) Very Weak: Activity
concentration between 20 and 800 μM, (e) Inactive: Activity concentration higher
than 800 μM.

(ii)

The AR pathway model (CoMPARA) was built by integrating 11 high-throughput
screening ToxCast/Tox21 in vitro assays into a computational network. Multiple
endpoints were utilized: receptor binding, coregulator recruitment, gene
transcription and protein production on multiple cell types.20 A chemical test set
composed of 158 androgen active and inactive chemicals were sourced from a
semi-automated systematic literature review and used as reference chemicals.
CoMPARA has balanced accuracies of 95.2% for agonist and 97.5% for
antagonist reference chemicals when compared to the reference set. Using the
CoMPARA model, chemicals are given a consensus value which determines
10

whether or not there was a consensus of agonist or antagonist activity between
reference data sets (0 for insignificant consensus, 1 for significant). Confidence
scoring for this model was assigned by AR pathway model AUC scores,
cytotoxicity information, and confirmation assay data. This model does not
include threshold defining class categories.
Using the CERAPP and CoMPARA model, chemicals present in crumb rubber were
prioritized based on a number of criteria. For ER relevant compounds, chemicals possessed an
agonist consensus of 1, a concordance of >= 0.5, were within or above the “Very Weak potency
category and lacked relevant EDC literature. AR relevant compounds possessed an antagonist
consensus of 1, a concordance of >= 0.5, and a lack of relevant literature on EDC potential.
Final chemicals selected were also chosen based on commercial availability.

2.2 | Literature Review and Active Site Identification
A literature search was conducted using the both the EPA’s Chemistry Dashboard interface
(https://comptox.epa.gov/) and a targeted search via the “PubMed Abstract Sifter” using the
following query: “ [CAS-RN] OR [chemical name] AND endocrine disruption OR female
reproduction OR fertility OR estrogen”. Relevant papers were, allowing for the identification of
crumb rubber chemicals with existing literature versus those that were understudied. Relevance
was attributed to a conclusive understanding of the chemical’s endocrine via literature search
when utilizing mammalian models or in vitro analysis, leaving 33 chemicals as seen in Figure 1.
Active nuclear receptor assays associated with each compound were retrieved from ToxCast;
compounds not registered in the database received a category of “N/A” under nuclear receptor
bioactivity in Table 1.
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Identify Organic Crumb Rubber Chemicals (n=306)

CoMPARA and CERAPP model prioritization (n=33)

Literature review (33 chemicals) and comparison with nuclear active
sites

ToxPi analysis for visualization

Selection of priority and commercially available testing set (n=4)

Figure 1. Overview of EDC chemical prioritization.

2.3 | ToxPi Analysis
The Toxilogical Prioritization Index (ToxPi) is a stand-alone, platform-independent Java
application developed to enable integration of multiple sources of evidence.21 ToxPi allows
transparent visual rankings with weighted inputs of each data source to facilitate prioritization
tasks Using ToxPi software. The culmination of CERAPP and CoMPARA model data along with
active site detection were visualized for the 33 prioritized chemicals. In looking at the total
estrogenic agonist effect of chemicals, the following data points were included in the ToxPi
analysis: (1) presence of an active ER binding site, (2) presence of an active AR binding site, (3)
estrogenic concordance binding quotient, (4) androgenic concordance binding quotient, (5)
estrogenic agonist quotient and (6) androgen antagonist quotient.

2.4 | Reagents

RPMI Medium 1640 (11835-030; Gibco), phenol red-free RPMI (11873-030, Gibco) and DMEM
were purchased from Invitrogen (Carlsbad, CA). Fetal bovine serum (FBS, F2442-500ML) was
purchased from Sigma-Aldrich (St. Louis, MO). Charcoal dextran-treated (stripped) FBS was
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purchased from Gemini Bio-Products (Sacramento, CA). Estradiol was purchased from
Steraloids Inc. (Newport, RI). TaqMan qRT-PCR primer-probes were purchased from Applied
Biosystems (ThermoFisher Scientific, Waltham, MA). Anti-Actin Antibody was purchased from
Milipore (MAB1501; Temecula, MA) and Estrogen Receptor alpha (D8H8) Rabbit mAb from Cell
Signaling Technologies (86445; Danvers, MA; Table S1). Goat Anti-Rabbit IgG, IRDye® 800CW
Conjugated secondary antibody (926-32211) and Goat anti-mouse IRDye 680RD Goat antiMouse IgG secondary antibody (926-68070) were both obtained from LI-COR Biosciences
(Lincoln, NE; Table S1). The four EDCs used in this study were purchased from Sigma Aldrich
and are as follows: 4-tert-octylphenol (TCI, T0144; purity 95.0% by GC), fluoranthene (TCI,
F0016; purity 98.0%), chrysene (Supelco, 40074; 1000ug/mL acetone, TraceCERT® Grade by
HPLC) and dibenz(a,h)anthracene (TCI, D0145; purity 98.0% by GC).

2.5 | Crumb Rubber Concentrated Media (CRCM)
50 g of Al’s Crumb Rubber (ALS-LC) purchased from Amazon.com was added to 500
mL of RPMI-1640 Phenol Red-free with 5% Stripped Heat inactivated FBS media or DMEM with
10% Stripped Heat Inactivated FBS media. Samples were kept at room temperature or in a
water bath at 37°C for 24 hours. Media with crumb rubber was shaken periodically during
incubation at room temperature or 37oC. Crumb rubber particles were removed from the media
using vacuum filtration.

2.6 | LDH cytotoxicity assay
Cells seeded on 6-well plates were treated for 24 hours with Veh (1XPBS), 1000 nM of
each selected EDC or 100% CRCM concentration. Following treatment, conditioned media was
collected and centrifuged at 1000 g for 5 minutes. Supernatant was assessed for LDH activity
using the Cytotoxicity Detection Kit (CYTODET-RO), purchased from Sigma Aldrich (Roche
Diagnostics, Mannheim, Germany), according to protocol. Briefly, 100-μL conditioned media
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was incubated with 100 μL reaction mixture for 15 minutes at room temperature, the reaction
was stopped with 50 μL stop solution, and samples were read on a Vmax microplate reader
(Molecular Devices, Sunnyvale, CA) at 490 nm wavelength.

2.7 | Ishikawa, Hep62 and MCF-7 cell culture
The immortalized Ishikawa uterine human endometrial adenocarcinoma cell line was
obtained from ATCC (American Type Culture Collection, Manassas, VA). Ishikawa and MCF-7
cells were then grown at 37°C in a standard tissue culture incubator, with 95% humidity and 5%
carbon dioxide. Cells were maintained in RPMI Medium 1640 supplemented with 5% FBS. 24
hours before treatment, media was changed to phenol red-free RPMI containing 5% charcoalstripped heat-inactivated FBS.
Ishikawa controls were treated with chemical diluent, at no greater than 0.01% Et-OH or
DMSO. Chemical-treated cells were treated with either 100 nM or 1000 nM of 4-OP dissolved in
Et-OH, fluoranthene dissolved in dimethyl sulfide (DMSO), chrysene dissolved in DMSO or
Dibenz(a,h)anthracene dissolved in DMSO for 6 hrs.
Immortalized HepG2 human liver cells were obtained from Dr. Vasilis Vasiliou at the
Yale School of Public Health, Department of Environmental Health Sciences. Cells were grown
at 37 C in a standard tissue culture incubator, as described above. Cells were maintained in
DMEM medium supplemented with 10% FBS.
CRCM was applied in solution concentrations of 6.25%, 12.5%, 25%, 50% and 100% for
6 hrs to all three cell types – Ishikawa, HepG2 and MCF-7.

2.8 | Quantitative RT-PCR (QRT-PCR)
Total RNA was extracted from 6-well plates using the Qiagen RNeasy mini kit (Qiagen,
Valencia, CA) according to manufacturer protocol with the deoxyribonuclease (DNase)
treatment performed on sample column. Isolated RNA was then assessed for purity and yield by
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evaluating the A260/280 and A260/230 using the NanoDrop One Spectrophotometer
(ThermoFisher Scientific, Waltham, MA). An absorbance ratio for 260/280 of 1.8 was utilized for
the identification of adequate samples and the 260/230 absorbance cutoff is 1.6. cDNA was
synthesized from 100 ng of total RNA using the One-Step RT-PCR Universal Master Mix
Reagent (ThermoFisher Scientific). Using the CFX Connect (CFX384, Bio Rad, Hercules, CA)
thermocycler, quantitative real-time polymerase chain reaction (qRT-PCR) was performed using
predesigned primer-probe sets (ThermoFisher Scientific) in a total 10-uL reaction volume.
Phases for thermocycling of the samples were sequenced: 48 C for 30 min, 95 C for 10 min, 40
cycles of 95 C for 15 seconds and finally 60 C for 60 seconds.
For each of the gene primer-probe sets utilized, technical duplicates were compared to a
standard curve and normalized against the chosen reference gene, peptidylprolyl isomerase B
(PPIB). PPIB was unaffected by EDC treatment. Analysis provided by this method is presented
as a fold change, with ANOVA or Student’s t-test to follow. Three to five biological replicates are
analyzed per treatment group.

2.9 | Western blotting
Following treatment with Tris-glycine SDS sample buffer supplemented with 2-mercaptoethanol
(BME), total protein was quantified using the Pierce 660 nm protein assay kit (Thermo Fisher
Scientific). SDS-PAGE separation was used to separate equivalent amounts of protein from
each sample prior to being transferred to a nitrocellulose membrane. Membranes were blocked
with 7.5% skim milk in Tris-buffered saline (TBS) and proved overnight with primary antibodies
against β-actin and ERα (Table S1). 24 hrs later, membranes were washed with 0.1% Tween20 (TBS-T) in TBS and incubated with secondary antibody for 1 hour at room temperature
(Table S1). The Odyssey LI-COR imaging system (LI-COR Biosciences, Lincoln, NE) was used
to visualize immunoreactivity. Protein levels were normalized to β-actin and expressed to control
samples.
15

2.10 | Statistical analysis
Data are presented as mean ± SE using a minimum of three biological replicates. Statistical
significance was determined by ANOVA with Tukey’s post hoc analysis. Statistical significance
is reported as either p < 0.05 (*) or p < 0.01 (**).

3 | Results
3.1 | Prioritization of chemicals in crumb rubber for further analysis
Based on the output from the CERAPP and CoMPARA models for the 30412 chemicals found in
crumb rubber, 33 chemicals were prioritized for their ER agonist or AR antagonist activity and
binding coherence (Table 1). Compounds were prioritized if they had either a positive (“1”) AR
antagonist consensus and an AR concordance >= 0.5 or a positive ER agonist concordance
(“1”) and an ER agonist concordance >= 0.5.
The prioritized chemicals are indicated in Table 1 (*). As a comparison, the chemical
structures of endogenous hormones, 17β-estradiol (E2) and total testosterone (TST), were
included below in Figure 2. Additional visualization was done in ToxPi software, shown in Figure
3 below. Each value within the pi was scaled from 0 to 1; for agonist or antagonist activity this
value was an output of the consensus and concordance values, presence of active nuclear
receptors was classified as 1 and absence as 0. For the purposes of this study, we selected
four chemicals for initial assays. Based on the ToxPi visualization, chrysene and fluoranthene
demonstrate similar activities on AR antagonist and ER agonist models. However, previous
fluoranthene research has identified active nuclear receptors while chrysene nuclear receptor
data is not available. Dibenz(a,h)anthracene demonstrated activity in all six categories but
lacked literature to support these findings. 4-tert-octylphenol (4-OP) was also a strong chemical
in terms of categorical indicators and a literature review for 4-OP found 46 relevant papers on
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estrogenic activity and EDCs. Both the contrasting data and similarities between chemicals
made these four our candidates for the starting set, outlined in Table 2.
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CASRN

Chemical name

56-55-3

Benz(a)anthracene

120-12-7

Anthracene

613-12-7

Anthracene, 2-methyl-

779-02-02

Anthracene, 9-methyl-

832-71-3

3-Methylphenanthrene

2531-84-2

2-Methylphenanthrene

475-20-7

junipene (longifolene)

13466-78-9

Structure

ER
Nuclear
AR
ER agonist
AR antagonist
agonist
receptor
Total relevant
antagonist
concordanc
consensus
consensu
bioactivity
literature
concordance
e
s
(Yes, No, N/A)
0

0.5263

1

0.7

Yes

5

0

0.85

1

0.666666667

Yes

0

0

0.5789

1

0.6

N/A

0

0

0.6

1

0.6

N/A

0

0

0.6316

1

0.6

N/A

0

0

0.5556

1

0.6

Yes

0

0

0.9048

1

0.555555556

Yes

0

0

1.0

1

0.555555556

Yes

0

0

0.9048

1

0.5

Yes

4

1

0.6842

1

1

Yes

46

1

0.6

1

0.7

N/A

2

1

0.5789

1

0.666666667

Yes

1

1

0.5714

1

0.666666667

N/A

2

1

0.7895

1

0.6

N/A

1

1

0.6363636364

1

0.6

Yes

0

3-carene

59-50-7

4-Chloro-3-methylphenol

140-66-9

4-tert-octylphenol*

218-01-9

Chrysene*

53-70-3

Dibenz(a,h)anthracene*

1740-19-8

Dehydroabietic acid

243-17-4

Benzo(b)fluorene

101-67-7

Benzenamine, 4-octyl-N-(4octylphenyl)-

N
H

3910-35-8

2,3-dihydro-1,1,3-trimethyl-3phenyl-1H-indene

1

0.611111111

1

0.5556

N/A

0

88-24-4

Phenol, 2,2'-methylenebis(6(1,1-dimethylethyl)-4-ethyl-

1

1.0

0

0.6364

Yes

0

91-94-1

3,3'-Dichlorobenzidine

1

0.8

0

0.8

Yes

0

206-44-0

Fluoranthene*

1

0.7895

0

0.5556

Yes

0
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2381-21-7

Pyrene, 1-methyl-

0203-12-3

Benzo(ghi)fluoranthene

781-43-1

9,10-Dimethylanthracene

192-97-2

Benzo(e)pyrene

205-99-2

Benzo(b)fluoranthene

129-00-0

Pyrene

0207-08-09

Benzo(k)fluoranthene

191-26-4

Anthanthrene

793-24-8

1,4-Benzenediamine, N-(1,3dimethylbutyl)-N'-phenyl-

1

0.7222222222

0

0.5455

Yes

0

1

0.705882353

N/A

N/A

N/A

0

1

0.7

0

0.6667

N/A

0

1

0.6666666667

0

0.5

Yes

1

1

0.65

0

0.5556

Yes

1

1

0.631578947

0

0.5

Yes

5

1

0.631578947

0

0.5556

N/A

6

1

0.625

N/A

N/A

N/A

0

1

0.6111111111

0

0.9

Yes

0

1

0.611111111

0

0.5

Yes
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1

0.611111111

0

0.5

Yes

0

1

0.611111111

0

0.5

Yes

0

1

0.5625

0

0.5

Yes

0

H
N

N
H

50-32-8

Benzo(a)pyrene

193-39-5

Indeno(1,2,3-cd)pyrene

198-55-20

Perylene

191-24-2

Benzo(g,h,i)perylene

Table 1. CoMPARA and CERAPP results for 33 prioritized chemicals. *Prioritized following targeted literature
review. ER agonists are non-shaded rows, EDCs suspect of both estrogenic and AR antagonist activity are shaded light
grey and progressively, those with solely AR antagonist properties are shaded in the darkest grey.
O

OH

H

H

H

H

H

H

O

O

testosterone

progesterone

Figure 2. Chemical structures of estrogen, testosterone and progesterone. Serving as a visible
reference to EDC structures.
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Figure 3. ToxPi prioritization of selected chemicals according to potential estrogenic activity
modifying parameters. The following key indicates color variables; Red: ER agonist, orange: ER
binding, pink: active ER receptor, blue: AR antagonist, green: AR binding, purple: active AR
receptor.
ER
agonist

ER
binding

Active ER
receptor

AR
antagonist

AR
binding

Active AR
receptor

Proven
literature

4-OP
Dibenz(a,h)anthracene
Fluoranthene
Chrysene

Table 2. Comparison of four selected EDCs for further study. Green indicates presence and red
absence of.
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3.2 | Cytotoxicity screening of four prioritized EDCs and CRCM.
To determine whether or not selected EDCs and CRCM induced cell toxicity, released
lactate dehydrogenase (LDH) was measured in the media of Ishikawa cells treated with 100%
CRCM, 1 uM of chrysene, 1 uM dibenz(a,h)anthracene, 1 uM 4-OP or 1 uM fluoranthene.
Compared to the control, release of LDH was increased as a result of exposure to CRCM,
suggesting that exposure to crumb rubber induces cell death in Ishikawa cells. Increases were
seen as a result of exposure to 1 uM concentrations of dibenz(a,h)anthracene, 4-OP and
fluoranthene (Figure 4) at a 6-hr treatment interval. No difference was seen upon treatment with
1 uM chrysene. CRCM treatment induced cell death and dibenz(a,h)anthracene, fluoranthene
and 4-OP as CRCM constituents demonstrated cytotoxic behavior (Fig. 4), although not to the

Absorbance Normalized to Control

height of the conditioned medium.
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Released LDH- 6hr

25
20
15
10
5
0
100% CRCM 1uM CHR

1uM DBZ

1uM 4OP

1uM FL

Figure 4. Response of cytotoxicity compared to control of 100% CRCM, 1 uM chrysene, 1 uM
dibenz(a,h)anthracene, 1 uM 4-OP, or 1 uM fluoranthene as measured by lactate
dehydrogenase (LDH) release in media. Assays are graphed as the ± SEM of 4 independent
experiments. * p < .05 and ** p < .01 as determined by ANOVA.
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3.3 | EDC activity as indicated by mRNa expression levels of Pgr, Nppc, and Greb1 in the
Ishikawa cells.
To evaluate estrogenic response, the expression of three known estrogen-responsive
genes was evaluated in the immortalized Ishikawa cell line following treatment with the four
prioritized EDCs: 4-OP, fluoranthene, chrysene and dibenz(a,h)anthracene for 6 hrs with 10 nM,
100 nM or 1000 nM concentrations with Ppib as the control. Response to treatment was
compared to the response of Ishikawa cells to 10 nM E2. Expression of well-known ER target
genes, progesterone receptor (Pgr), growth regulating estrogen receptor binding 1 (Greb1), and
natriuretic peptide C (Nppc)22,23 was quantified by qRT-PCR. E2 treatment was used as the
positive control and peptidylprolyl isomerase B (Ppib) was used as the reference gene. The
10nM concentration of E2 induced expression of Pgr (Fig. 5A), Nppc (Fig. 5E) and Greb1 (Fig.
5H) compared to the reference.
The transcript levels of Pgr, Nppc, and Greb1 in 4-OP treated Ishikawa cells were
significantly elevated in both the 100nM and 1000 nM treatments (Fig. 5A) compared to vehicle
treated cells. 4-OP concentrations of 1000 nM showed similar or greater upregulation than the
10 nM E2 treatment. Pgr and Nppc in fluoranthene treated cells was upregulated by 10nM
treatments and a statistically significant increase in mRNA expression was seen in the 1000 nM
treatments (Fig. 5B). Significant downregulation was measured in dibenz(a,h)anthracene
treated cells at both 100nm and 1000nm treatments (Fig. 5D). E2 treatment at 10 nM
demonstrated significant upregulation in Nppc expression when compared to the control (Fig.
5E). Following exposure, significant Nppc upregulation was demonstrated in 4-OP treatments at
both 100 nM and 1000 nM at (Fig. 7E). Insignificant upregulation of Nppc mRNA expression
was seen in both 10nM and 100 nM concentration treatments of fluoranthene (Fig. 5F), and
similarly with chrysene (Fig. 5G). Dibenz(a,h)anthracene treatment resulted in an insignificant
downregulation of mRNA Nppc expression (Fig. 5H). Chrysene showed almost no difference in
mRNA expression compared to the control across all three genes (Fig. 5K), while
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dibenz(a,h)anthracene showed consistent downregulation in mRNA expression. Significant
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Figure 5 (A-K). mRNA expression in the Ishikawa cell line of Pgr, Nppc, and Greb1 compared
to control gene Ppib in fold-units. E2 treatment was given in 10 uM concentrations. Ishikawa
cells were 100 nM and 1000 nM concentrations of 4-OP, fluoranthene, chrysene and
dibenz(a,h)anthracene. For all qRT-PCR experiments, mRNA levels were normalized to PPIB and
set relative to 0 nmol/L or Veh. Genetic expression is graphed as the ± SEM of 4 independent
experiments. * p < .05 and ** p < .01 as determined by ANOVA.
3.4 | ESR1 and ESR2 mRNA expression, ERα absorption in EDC-treated Ishikawa cells.
To assess whether Ishikawa cells are receptive to hormone disruption by the prioritized
EDCs, expression of estrogen receptors ESR1 and ESR2 in addition to ERα protein was
determined via qRT-PCR. Western blot analysis was utilized to confirm expression level of ERα
after 6 h treatment compared to vehicle. Previous genetic research has demonstrated similarity
of function in genetic regulation in regard to ESR1 between endogenic and exogenic estrogens,
such as Bisphenol-A.24 mRNA expression for E2 treated Ishikawa cells was significantly lower
compared to the vehicle expression levels for ESR1 (Fig. 8A). Similarly, 4-OP, fluoranthene,
and dibenz(a,h)anthracene all demonstrated significant levels of downregulation compared to
the vehicle (Fig. 8A). Chrysene did not demonstrate a significant relative difference in mRNA
expression compared to the control.
E2 treatment with supplementary western blot analysis shows a decrease in ERα protein
level.25 ERα levels were significantly downregulated in the 4-OP treatment group, with
confirmation of activity within dibenz(a,h)anthracene, fluoranthene and chrysene treatments.
(Fig. 8B). Fluoranthene significantly upregulated ESR2 expression, while dibenz(a,h)anthracene
treatment resulted in statistically significant downregulation of ESR2 expression compared to
the vehicle.
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Figure 6. (a) ESR1 and (b) ERα mRNA expression under vehicle, estradiol, 4-OP, fluoranthene,
chrysene and dibenz(a,h)anthracene treatment groups relative to the Ppib reference treatment,
with supplemental (c) western blot analysis. (d) ESR2 expression relative to the Ppib reference
group, showing expression as an outcome of vehicle, 4-OP, fluoranthene, chrysene and
dibenz(a,h)anthracene treatments. Genetic expression is graphed as the ± SEM of 4
independent experiments. * p < .05 and ** p < .01 as determined by ANOVA.
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3.5 | Endogenous simulation of Pgr, Greb1 and Nppc expression in EDC-treated Ishikawa
cells.
Endogenous conditions were simulated by treating Ishikawa cells with both the EDC and
E2, observing mRNA expression from three genes. Pgr expression as a result of 4-OP was
antagonized by E2 treatment. Expression of Pgr due to treatment of fluoranthene (Fig.7D),
chrysene (Fig. 7G) and dibenz(a,h)anthracene (Fig. 7J) were agonized by the presence of E2 in
treatment conditions. While the 4-OP + E2 treatment antagonized both individual expressions of
4-OP and E2 in Greb1 (Fig.7B), we saw that the addition of E2 in other treatment groups had an
agonist effect. The sum expression of Greb1 in E2 + fluoranthene, chrysene or
dibenz(a,h)anthracene treatments was greater than that of solely the EDC. Similarly, expression
of Nppc was upregulated in by estradiol for fluoranthene, chrysene and dibenz(a,h)anthracene
treatments. Expression of Nppc in Ishikawa cells was downregulated from the singular 4-OP
treatment group to the E2 supplementation.
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Figure 7 (A-L). Comparison of EDC, E2 and combined (E2 + EDC) effects on Pgr, Greb1 and

Nppc expression in Ishikawa cells. Expression is graphed as the ± SEM of 4 independent
experiments. * p < .05 and ** p < .01 as determined by ANOVA.
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3.6 | LDH leakage with CRCM dose treatments across Ishikawa, HepG2 and MCF-7 cells
at both 6 and 24 hrs.
Ishikawa cells showed a steady decline in LDH release complimentary to diminishing
concentrations across both temperature groups for 6 hr assays, while 24 hr assays showed less
of a dose-response relationship. At 24 hr exposures, 100%, 50% and 25% groups all reached
30x fold compared to the vehicle across both temperature groups. 12.5% concentration at 37 C
reached 25x fold in LDH release compared to vehicle.
HepG2 cell treatments showed a dose-response release of LDH at the 6 hr time interval.
This relationship was less visible in the 24 hr treatment group. MCF-7 cells were the least
affected comparatively, with heated 6 hr treatments showing the greatest cytotoxic outcome.
Cytotoxicity was measured in all treatment groups at both time intervals for all cell types.
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Figure 8. Released LDH in Ishikawa, HepG2 and MCF-7 6 hr cell treatments of room
temperature and heated 37 C mediums at 100, 50, 25, 12.5 and 6.25% concentrations.
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Figure 9. Released LDH in Ishikawa, HepG2 and MCF-7 24 hr cell treatments of room
temperature and heated 37 C mediums at 100, 50, 25, 12.5 and 6.25% concentrations.
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3.7 | CRCM upregulate Greb1 mRNA expression in Ishikawa cells under 37 C treatment.
Among all four medium treatment types, only the 37 C prepared 24-hr incubation with 12.5%
concentration treatment showed significant upregulation in Greb1 expression. Other treatment
groups showed slight downregulation but no significant alterations in mRNA expression.

Relative mRNA Expression

GREB1
2.5

**

2
1.5
1
0.5
0
RT 6.25% RT 12.5%

37C
6.25%

37C
12.5%

Figure 10. GREB1 expression in Ishikawa cells after treatments with varying CRCMs. Treatment groups
of were classified as room temperature or heated to 37 C for 24 hr. Each treatment type was further
diluted to 6.25% and 12.5% concentrations. Greb1 expression is graphed as the ± SEM of 4

independent experiments. * p < .05 and ** p < .01 as determined by ANOVA.

4 | Discussion
Overall, the data collected in this study elucidate how we might juxtapose emerging
QSAR models with more traditional forms of research and the black box around complex
mixtures.
LDH release assays demonstrated that CRCM exerts cytotoxic effects on all three cells
lines tested in this study (Ishikawa, HepG2, and MCF-7). Previous work by the National Toxicity
Program (NTP) demonstrated cytotoxicity in HaCaT, HPL-1D and FHs-74-Int cell types,
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representative of skin, lung epithelial, and small intestinal cells in vitro.26 HepG2 cells of the
liver represent a portion of the digestive system, which could be directly in contact with crumb
rubber particles ingested by individuals. Unintentional inhalation and ingestion of crumb rubber
particles are cited by the NTP as potential exposure pathways. Utilizing the CRCM in LDH
studies also showed the stark difference in cytotoxicity profiles of mixtures versus that of
individual chemicals, the most common approach used today (Fig. 4).
Increased expression of Greb1 as an outcome of CRCM exposure was found only in the
37 C treatment at 12.5% concentration (Fig 10). In vitro studies mentioned earlier also included
heating treatments of 60 C. We did not treat the crumb rubber to temperatures above 37 C in
this research, but the potential to further increase temperature and thus leachability of
chemicals exist. With this in mind, further cytotoxicity and gene interaction is a potential
outcome. Additionally, previous work by the NTP have not looked at beyond cytotoxic
outcomes. Therefore, this data is the first insight into reproductive mechanisms by which crumb
rubber has the potential to mediate reproductive effects.
Related to the chemical prioritization step conducted in this study, the NTP’s also
attempted to select specific chemicals involved in the vulcanization of crumb rubber but labeled
this selection as “untargeted”. The selection did not involve any QSAR analyzation, unlike the
methods used in the endocrine profiling portion of this study. Here we see that the EDCs
chosen for further in vitro testing in our study all have significant potential to contribute to the
overall cytotoxicity and gene expression fluxes of CRCM. Although we are unsure as to whether
the chemicals previously identified in the crumb rubber study are also present in “Al’s Crumb
Rubber”, chemicals tested in the study were purposefully chosen as not having substantial
scientific literature on the EDC potential. Therefore, these findings also contribute to the overall
literature on endocrine effects of fluoranthene, dibenz(a,h)anthracene and chrysene in
particular, outlining effects on target genes and the estrogen receptor pathway. While
insignificant findings for chrysene were in line with one previous study,27 our study also shows
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significant upregulation of ERα and significant upregulation of Greb1 and Nppc with
supplemental E2, indicative of estrogenic behavior. We found zero relevant papers on
fluoranthene activity. The findings of this study indicate significant upregulation of Pgr and Nppc
in fluoranthene treatments. Endogenous treatment with E2 + fluoranthene demonstrated
significant increases in Greb1 and Nppc, suggesting estrogenic potential. 4-OP estrogenic
activity was confirmed across all analyses. Significant interference was seen in ESR1 and ESR2
mRNA expression for dibenz(a,h)anthrancene in addition to downregulation of PGR, showing
potential for estrogenic interaction despite a previous study claiming antagonist activity.28 Our
findings on chrysene were more in line with predictions produced by the CoMPARA and
CERAPP models (Table 2).

5 | Conclusions
Further discussion is needed to determine the implications of these results being that methods
used in this study need to be further extrapolated into exposure models. Based on the findings
of this study, crumb rubber is a potential mediating factor for harmful outcomes in both the male
and female reproduction systems.

6 | Supplemental Tables
Table S1: Antibodies
Antibody ID

Antibody

Source

AB_2223041

Anti-Actin
Antibody, clone
C4
Estrogen
Receptor alpha
(D8H8) Rabbit
mAb
Goat Anti-Rabbit
IgG, IRDye®
800CW

Millipore,
Temecula, MA

AB_2617128

AB_621843

Catalog
Number
MAB1501

Purpose

Cell Signaling
Technology
Danvers, MA

86445

Western blotting
(1:1,000)

LI-COR
Biosciences,
Lincoln, NE

926-32211

Western blotting
(1:3,000)

Western blotting
(1:3,000)
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Conjugated
secondary
antibody
AB_10956588

Goat anti-mouse
IRDye 680RD
Goat anti-Mouse
IgG (H + L), 0.5
mg secondary
antibody

LI-COR
Biosciences,
Lincoln, NE

926-68070

Western blotting
(1:3,000)

Table S2: TaqMan Real-Time PCR Primers
Primer

Gene

Description

Hs00168719

PPIB

Peptidylprolyl isomerase B

Hs00536409

GREB1

Hs01556702

PGR

Growth regulation estrogen
receptor binding 1
Progesterone receptor

Hs00360930

NPPC

Natriuretic peptide C

Hs01046816

ESR1

Estrogen receptor 1

Hs01100353

ESR2

Estrogen receptor 2
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